ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

0R34 Johnson & Johnson

148.60
-1.30 (-0.87%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Johnson & Johnson 0R34 London Ordinary Share
  Price Change Price Change % Share Price Last Trade
-1.30 -0.87% 148.60 01:35:05
Open Price Low Price High Price Close Price Previous Close
148.60 149.90
more quote information »

Recent News

Date Time Source Heading
01/5/202423:17ALNCNewsTOP NEWS: J&J proposes USD6.48 billion settlement of cancer..
16/4/202420:54ALNCNewsTOP NEWS: Johnson & Johnson upgrades guidance on swing to..
05/4/202422:02ALNCNewsTOP NEWS: J&J swoops for Shockwave Medical in USD13.1..
26/3/202405:28ALNCNewsIN BRIEF: J&J submits US premarket approval application for..
18/3/202422:10ALNCNewsIN BRIEF: Johnson & Johnson receives FDA recommendation for..
24/2/202405:32ALNCNewsIN BRIEF: Johnson & Johnson gets EMA nod for Carvykti in..
02/2/202417:22ALNCNewsTOP NEWS: US sends drugmakers initial offers in Medicare..
23/1/202422:41ALNCNewsTOP NEWS: Johnson & Johnson eyes future growth; 2023 sales..
20/1/202408:34ALNCNewsIN BRIEF: J&J gets US FDA approval for cancer treatment..
06/12/202300:24ALNCNewsTOP NEWS: J&J expects strong long-term growth in three key..
23/10/202322:03ALNCNewsJ&J report slew of positive trial results focused on various..
17/10/202321:46ALNCNewsTOP NEWS: J&J raises full-year sales outlook after "solid"..
07/10/202302:52ALNCNewsIN BRIEF: J&J applies for indication extension to EMA for..
04/10/202303:00ALNCNewsDrugmakers agree to US government price talks amid pushback
07/9/202315:50ALNCNewsJ&J's Janssen ends Phase 3 MACiTEPH study evaluating..
31/8/202302:07ALNCNewsTOP NEWS: J&J forecasts strong growth in earnings after..
11/8/202306:34ALNCNewsIN BRIEF: Johnson & Johnson's blood cancer therapy approved..
20/7/202321:30ALNCNewsTOP NEWS: J&J ups full-year guidance after "robust" second..
31/5/202301:48ALNCNewsJ&J seeks FDA approval for pulmonary arterial hypertension..
10/5/202305:23ALNCNewsJ&J says Tremfya data shows positive results for ulcerative..

Your Recent History

Delayed Upgrade Clock